PMID: 3013771Jun 1, 1986

Biological actions of leukotrienes. State of the art lecture

Hypertension
A W Ford-Hutchinson, G Letts

Abstract

Leukotrienes are novel mediators derived from arachidonic acid through the 5-lipoxygenase enzyme system. Leukotriene B4 has potent effects on leukocyte function and in vivo induces leukocyte accumulation and changes in vascular permeability and modulates pain responses. Peptido-lipid leukotrienes are potent smooth muscle--contracting agents. They may have important cardiovascular actions through mechanisms involving either vasoconstriction or indirect vasodilatation. Evidence for leukotriene production has been found in subjects with allergic conditions and psoriasis, indicating a putative role for these substances in human disease.

References

May 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P Borgeat, B Samuelsson
Jan 1, 1985·Annals of the New York Academy of Sciences·E SchachtR Duncan
Feb 1, 1985·The Journal of Investigative Dermatology·C C Chan, A W Ford-Hutchinson
Apr 1, 1985·The American Review of Respiratory Disease·T AhmedL Yerger
Apr 1, 1985·Prostaglandins·S BrainS Charleson
Jul 1, 1985·The British Journal of Dermatology·K KragballeJ J Voorhees
Oct 1, 1985·The Journal of Investigative Dermatology·C C ChanA Ford-Hutchison
Sep 16, 1985·Biochemical and Biophysical Research Communications·D J NathanielA W Ford-Hutchinson
Jan 1, 1985·International Archives of Allergy and Applied Immunology·P J Piper
Feb 1, 1985·Anesthesiology·C M AlexanderB E Marshall
Jan 1, 1985·Prostaglandins·P J PiperL J McLeod
Aug 27, 1985·European Journal of Pharmacology·S Barst, K Mullane
Apr 19, 1985·Science·R Spector, E J Goetzl
May 29, 1985·Biochimica Et Biophysica Acta·J F EvansA W Ford-Hutchinson
Sep 1, 1984·The Journal of Allergy and Clinical Immunology·A W Ford-Hutchinson
Jun 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·A M LeferJ B Smith
Dec 15, 1984·Biochemical Pharmacology·J H FleischW S Marshall
Jul 1, 1980·The Journal of Pharmacy and Pharmacology·M J SmithM A Bray
Mar 1, 1981·British Journal of Pharmacology·M A BrayM J Smith
Aug 1, 1981·Prostaglandins·M A BrayM J Smith
Feb 26, 1982·Biochemical and Biophysical Research Communications·S H SalariW S Powell
Oct 29, 1982·Biochemical and Biophysical Research Communications·M Rola-PleszczynskiP Sirois
Feb 1, 1983·The Journal of Investigative Dermatology·N A SoterK F Austen
Dec 17, 1982·European Journal of Pharmacology·O L Woodman, G J Dusting
May 1, 1983·The American Journal of Cardiology·D EzraR E Goldstein
Jun 15, 1983·Biochemical and Biophysical Research Communications·M Rola-PleszczynskiP Sirois
Nov 1, 1983·British Journal of Pharmacology·R CampM J Walport
Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S S Pong, R N DeHaven
Jun 21, 1984·The New England Journal of Medicine·P S CreticosL M Lichtenstein
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D G PayanE J Goetzl
Mar 16, 1984·European Journal of Pharmacology·A Dembinska-KiećB A Peskar
May 1, 1984·Prostaglandins·G Feuerstein
Aug 3, 1984·European Journal of Pharmacology·S E GreenwaldP J Piper
Jul 1, 1983·Prostaglandins, Leukotrienes, and Medicine·P TagariD J Boullin
May 1, 1983·Prostaglandins·M J Panzenbeck, G Kaley
Sep 1, 1983·Experimental Eye Research·J B Lombardini, S D Prien
Mar 1, 1984·European Heart Journal·V B FiedlerT S Abram
Jul 17, 1981·European Journal of Pharmacology·P BhattacherjeeK E Eakins
Nov 1, 1980·Acta Physiologica Scandinavica·P HedqvistB Samuelsson
May 1, 1982·British Journal of Pharmacology·L G Letts, P J Piper
Aug 1, 1981·The American Journal of Cardiology·J Mehta, P Mehta
Jun 1, 1982·Prostaglandins·H BisgaardJ Søndergaard

Citations

Oct 17, 1987·Biochimica Et Biophysica Acta·A FosterL G Letts
Jun 1, 1989·Prostaglandins·P TagariJ Rokach
Apr 1, 1991·European Journal of Clinical Investigation·E GulbinsM Steinhausen
Jul 1, 1992·Prostaglandins, Leukotrienes, and Essential Fatty Acids·I Heinroth-HoffmannH J Mest
Mar 1, 1989·American Journal of Orthodontics and Dentofacial Orthopedics : Official Publication of the American Association of Orthodontists, Its Constituent Societies, and the American Board of Orthodontics·A H MohammedR Dziak
Dec 3, 2014·Seminars in Immunology·Murugesan V S RajaramLarry S Schlesinger
May 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·A FosterJ Rokach
Nov 1, 1992·Annals of the Rheumatic Diseases·P B CostelloF A Green

Related Concepts

Arachidonate Lipoxygenases
Eicosatetraenoic Acids
Cardiovascular System
Leukocytes
Leukotrienes B
SRS-A
Arachidonic Acid, Zinc Salt, (all-Z)-Isomer
Arachidonate 15-Lipoxygenase Inhibitors

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Systemic Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis is a rare rheumatic disease that affects children. Symptoms include joint pain, but also fevers and skin rashes. Here is the latest on this disease.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Pontocerebellar Hypoplasia

Pontocerebellar hypoplasias are a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. Here is the latest research on pontocerebellar hypoplasia.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.

Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.